Reuters logo
2 个月前
BRIEF-Protalix Biotherapeutics says presentation of clinical trial results for alidornase alfa
2017年5月23日 / 中午11点52分 / 2 个月前

BRIEF-Protalix Biotherapeutics says presentation of clinical trial results for alidornase alfa

1 分钟阅读

May 23 (Reuters) - Protalix Biotherapeutics Inc

* Protalix Biotherapeutics announces presentation of Phase II clinical trial results for Alidornase Alfa in cystic fibrosis at the 40th European cystic fibrosis society conference Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below